The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices

Transfusion and Apheresis Science

Volumn 33, Issue 1, 2005, Pages 63-69

  Depasse, François ^a   Sensebé, Luc ^b   Seghatchian, Jerard ^c   Andreu, Georges ^b   Samama, Meyer Michel ^a,d  

^a Laboratoire LCL   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Blood Components/Apheresis Technology and Haemostasis/Thrombosis Consultancy   (United Kingdom)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BATROXOBIN; BLOOD CLOTTING FACTOR; FIBRINOGEN; METHYLENE BLUE; THROMBIN;

ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DYSFIBRINOGENEMIA; FIBRIN POLYMERIZATION; FIBROGENESIS; HUMAN; LEUKAPHERESIS; PHOTOSTIMULATION; SEPARATION TECHNIQUE; THROMBIN TIME; VIRUS INACTIVATION;

BLOOD PRESERVATION; ENZYME INHIBITORS; FIBRIN; FIBRINOGEN; HUMANS; LIGHT; METHYLENE BLUE; PLASMA; VIRUS INACTIVATION;

EID: 22144477855     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.02.002     Document Type: Article

References (29)

1. B. Lambrecht, H. Mohr, J. Knuver-Hopf, and H. Schmitt Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light Vox Sang 60 1991 207 213
2. S.J. Wagner Virus inactivation in blood components by photoactive phenotiazine dyes Transfus Med Rev 16 2002 61 66
3. T. Zeiler, H. Riess, G. Wittmann, G. Hintz, R. Zimmermann, and C. Muller The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma Transfusion 34 1994 685 689
4. V.S. Hornsey, P. Krailadsiri, S. Mc Donald, J. Seghatchian, L.M. Williamson, and C.V. Prowse Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma Br J Haematol 109 2000 665 670
5. Y. Inada, H. Hessel, J. Knuver-Hopf, and H. Schmitt Photooxidation of fibrinogen in the presence of methylene blue and its effects on polymerization Biochem Biophys Acta 532 1978 161 170
6. R. Atance, A. Pereira, and B. Ramirez Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitates Transfusion 41 2001 1548 1552
7. J. Seghatchian, and P. Krailadsiri The quality of methylene blue light treated FFP and Cryoprecipitate Transfus Apher Sci 25 2001 227 231
8. A.M. Suontaka, M. Bloomback, and J. Chapman Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light Transfusion 43 2003 568 575
9. M. Garwood, R.A. Cardigan, O. Drummond, V.S. Hornsey, C.P. Turner, and D. Young The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma Transfusion 43 2003 1238 1247
10. P. Hellstem, and H. Haubelt Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy Thrombos Res 107 2002 83 88
11. F. Depasse, G. Andreu, L. Sensébé, J. Seghatchian, and M.M. Samama Qualitative alteration of fibrinogen in methylene-blue-phototreated plasma Blood 102 2003 4236 [Abstract]
12. J. Seghatchian, and J.P. Allain Current strategies for the provision of safer plasma and its derivatives: an update Transfus Apher Sci 25 2001 185 187
13. L.M. Williamson, R. Cardigan, and C.V. Prowse Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety (review)? Transfusion 43 2003 1322 1329
14. J. Pennigton, G.P. Taylor, J. Sutherland, R.E. Davis, J. Seghatchian, and J.P. Allain Persistance of HTLV-1 in blood components after leukocyte depletion Blood 100 2002 677 681
15. F. Haverkate, and M. Samama Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen Thromb Haemost 73 1995 151 161
16. M.M. Samama, and F. Haverkate Hereditary dysfibrinogenemia, afibrinogenemia, hypofibrinogenemia and thrombosis M.J. Seghatchian M.M. Samama S.P. Hecker Hypercoagulable states: fundamental aspects, acquired disorders and congenital thrombophilia 1996 CRC Press Boca Raton, USA
17. J. Martinez Congenital dysfibrinogenemia Curr Opin Hematol 4 1997 357 365
18. T. Hayes Dysfibrinogenemia and thrombosis Arch Pathol Lab Med 126 2002 1387 1390
19. D. Crettaz, L. Sensebe, D.H. Vu, P. Schneider, F. Depasse, and W.V. Bienvenut Proteomics of methylene blue photo-treated-plasma before and after removal of the dye by an adsorbent filter Proteomics 4 2004 881 891
20. Pohl U, Weiding JU. Treatment of patients with severe congenital coagulation factor V or XI deficiency with methylene blue virus inactivated Plasma. In: ISBT European Congress Proceedings, Italy; 1995.
21. Pohl U, Becker B, Papstein C. Methylene blue virus inactivated fresh frozen plasma in the treatment of patients with thrombotic thrombocytopenic purpura. In: ISBT Meeting Proceedings, Japan; 1996.
22. J. De La Rubia, F. Arriaga, and D. Linares Role of methylene-blue-treated or fresh plasma in the response to plasma exchange in patients with thrombotic thrombocytopic purpura Br J Haematol 114 2001 721 723
23. A.C. Simonson, and H. Sorensen Clinical tolerance of methylene blue virus-inactivated plasma Vox Sang 77 1999 210 217
24. J.P. AuBuchon, C. Pickard, L.O. Herschel, J.P. Corner, and E. Lee Removal of methylene blue from plasma via an adsorbent filter Vox Sang 74 1998 1 6
25. J.U. Wieding, J. Rathgeber, D. Zemker, U. Pohl, and M. Kohler Prospective, randomised and controlled study on solvent/detergent versus methylene blue light virus-inactivated plasma Transfusion SV 1999 23
26. Serious Hazards of Transfusion Annual Report, 2000-2001. In SHOT Steering Committee; 2002.
27. T. Burnouf, C. Kappelsberger, K. Frank, and T. Burkharrdt Residual cell content in plasma produced by three centrifugal apheresis procedures Transfusion 43 2003 1522 1526
28. J. Seghatchian The quality of clinical FFP, cryoprecipitate, cryosupernatant-derived from single donor apheresis procedures and random donations collected in BAT system: assessment of the quality states of FVIII, contact activation, microvesicule content and cytokines Transfus Sci 18 1997 115 118
29. P. Krailadsiri, J. Seghatchian, and A.P. Bode Microvesicles in blood components: Laboratory and clinical aspects (review) Clin Appl Hemost Thromb 18 1997 86 95